We found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitleRituximab is effective in the treatment of refractory Churg-Strauss syndrome and is associated with diminished T-cell interleukin-5 production.AuthorsPepper RJ; Fabre MA; Pavesio C; Gaskin G; Jones RB; Jayne D; Pusey CD; Salama ADPublicationRheumatology (Oxford, England), 2008, Vol 47, Issue 7, p1104ISSN1462-0332Publication typearticleDOI10.1093/rheumatology/ken175